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Despite ongoing research investigating mechanisms of coronavirus replication, functions of many viral nonstructural proteins (nsps)
remain unknown. In the current study, a reverse genetic approach was used to define the role of the 28-kDa amino-terminal product (nsp1) of
the gene 1 polyprotein during replication of the coronavirus murine hepatitis virus (MHV) in cell culture. To determine whether nsp1 is
required for MHV replication and to identify residues critical for protein function, mutant viruses that contained deletions or point mutations
within the nsp1-coding region were generated and assayed for defects in viral replication, viral protein expression, protein localization, and
RNA synthesis. The results demonstrated that the carboxy-terminal half of nsp1 (residues K124 through L241) was dispensable for virus
replication in culture but was required for efficient proteolytic cleavage of nsp1 from the gene 1 polyprotein and for optimal viral replication.
Furthermore, whereas deletion of nsp1 residues amino-terminal to K124 failed to produce infectious virus, point mutagenesis of the nsp1
amino-terminus allowed recovery of several mutants with altered replication and RNA synthesis. This study identifies nsp1 residues
important for protein processing, viral RNA synthesis, and viral replication.
D 2005 Elsevier Inc. All rights reserved.Keywords: Coronavirus; Replication; Reverse genetics; Nonstructural protein; Protein processing; RNA synthesisIntroduction
Coronaviruses belong to a family of enveloped positive-
strand RNA viruses that are responsible for devastating
illnesses in livestock and domestic animals. The identi-
fication of a novel human coronavirus as the etiological
agent of Severe Acute Respiratory Syndrome (SARS) in
2003 highlighted the potential of this virus family to also
cause severe human disease (Kuiken et al., 2003). Even
with continuing research addressing how coronaviruses
replicate and cause disease, the functions of many viral0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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nonstructural proteins (nsps) are expressed from coronavi-
rus gene 1 polyproteins, but at least seven of these nsps
have no known roles in viral replication. In the past, gene 1
has been referred to as the ‘‘replicase gene’’ and gene 1
nsps as ‘‘replicase proteins’’ named by their molecular
weight in kilodaltons. More recently, nsps have been
named based on their order in gene 1 and are numbered
consecutively beginning at the amino-terminus of the
polyprotein (i.e., nsp1 through nsp16) (Harcourt et al.,
2004; Prentice et al., 2004b; Snijder et al., 2003). The gene
1 nsps of the coronavirus murine hepatitis virus (MHV) are
similar in number, size, and organization to those of SARS
coronavirus (SARS-CoV) (Marra et al., 2003; Snijder et al.,
2003). This resemblance suggests that MHV is an excellent
model for studies of coronavirus nsp function and may05) 209 – 223
S.M. Brockway, M.R. Denison / Virology 340 (2005) 209–223210increase our understanding of SARS-CoV replication and
pathogenesis.
Following entry of MHV into a host cell, the first event
in the virus life cycle is translation of two polyproteins from
gene 1 of the input RNA genome. Gene 1 is comprised of
two overlapping open reading frames (ORF1a and ORF1b)
that are connected by a 1 ribosomal frameshift (Fig. 1A)
(Bonilla et al., 1994; Bredenbeek et al., 1990; Brierley et al.,
1989; Lee et al., 1991; Pachuk et al., 1989). Translation of
either ORF1a or the ORF1ab fusion results in possible 495-
kDa or 803-kDa polyproteins, respectively. These co-amino-
terminal polyproteins are proteolytically processed by three
virus-encoded proteinases, including two papain-like pro-
teinases (PLP1 and PLP2 within nsp3) and a picoronavirus
3C-like proteinase (nsp5), to yield at least 16 mature gene 1
nsps as well as intermediate precursors. To date, all MHV
gene 1 nsps tested co-localize with sites of active viral RNA
synthesis at cytoplasmic viral replication complexes on
intracellular double-membrane vesicles (Bost et al., 2000,
2001; Brockway et al., 2003, 2004; Gosert et al., 2002;
Prentice et al., 2004a; Shi et al., 1999; van der Meer et al.,
1999). Nsps are thought to mediate replication of the MHV
RNA genome and subgenomic RNA synthesis at theseFig. 1. Schematics of the MHV gene 1 polyproteins and nsp1 mutants. (A) Organiz
a line, and the locations of gene 1 (22 kb) and genes 2–7 (10 kb) are indicated. G
ORF1a–ORF1b fusion polyprotein is illustrated with mature nonstructural protein
terminal cleavage product (nsp1). Nsps with confirmed or predicted functions incl
proteinase (3CLpro; nsp5), two trans-membrane proteins (MP1 and MP2; nsp4 and
RNA helicase (Hel; nsp13), the 3V-to-5V exonuclease (Exo; nsp14), the endoribonuc
mutant proteins. The schematics illustrate the engineered deletions and point muta
and the predicted protein size (in kilodaltons) is listed to the right of each. The am
below the bottom nsp1 protein. The asterisks (*) indicate mutants that did not est
electroporated cells.membrane-bound complexes. However, the viral protei-
nases are the only MHV nsps with experimentally con-
firmed functions (Baker et al., 1989; Bonilla et al., 1995; Lu
et al., 1996; Lu et al., 1995). Based on homology to proteins
with known functions, roles in viral RNA synthesis have
been predicted for several other MHV gene 1 nsps. These
proteins include two trans-membrane scaffolding proteins
(nsp4 and nsp6) (Gosert et al., 2002), an RNA-dependent
RNA polymerase (nsp12) (Cheng et al., 2005; Gorbalenya
et al., 1989; Lee et al., 1991), an RNA helicase (nsp13)
(Seybert and Ziebuhr, 2001; Seybert et al., 2000), and
several RNA processing enzymes (nsp14, nsp15, and
nsp16) (Bhardwaj et al., 2004; Ivanov et al., 2004; Thiel
et al., 2003; Ziebuhr, 2005). Currently, there are no known
or envisaged functions in replication for at least seven MHV
gene 1 proteins (nsp1, nsp2, and nsp7–11).
Previous studies have provided intriguing evidence about
the potential functions of the 28-kDa amino-terminal protein
nsp1 (previously referred to as p28) in MHV replication.
The kinetics of nsp1 expression suggest that it might have
an early regulatory role during the viral life cycle. Nsp1 is
the first mature protein processed from the gene 1
polyprotein and is likely cleaved quickly following trans-ation of the MHV gene 1 polyprotein. The 32-kb MHV genome is shown as
ene 1 is composed of two open reading frames (ORF1a and ORF1b). The
(nsps) represented as numbered boxes. The gray box represents the amino-
ude: two papain-like proteinases (PLP1 and PLP2 within nsp3), the 3C-like
nsp6, respectively), the RNA-dependent RNA polymerase (Pol; nsp12), the
lease (Endo; nsp15), and the RNA methyltransferase (MT; nsp16). (B) Nsp1
tions within nsp1. Nsp1 amino acid numbers are listed below each protein,
ino-terminal charge-to-alanine mutations for each VUSB mutants are listed
ablish productive infections as determined by lack of recovered virus from
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Denison and Perlman, 1987; Denison and Perlman, 1986;
Denison et al., 1992, 1995). MHV mutants that are
incapable of liberating nsp1 from the nascent polyprotein
exhibit delayed replication, diminished peak titers, small
plaques, and reduced RNA synthesis compared to wild-type
controls (Denison et al., 2004). These results emphasize the
importance of nsp1 cleavage for optimal viral RNA
synthesis and suggest that nsp1 might play an important
role at MHV replication complexes. In support of this
notion, nsp1 localizes to replication complexes in the
infected cell cytoplasm during times of peak viral RNA
synthesis, and biochemical experiments demonstrate inter-
actions between nsp1 and two other replication complex-
associated proteins (nsp7 and nsp10) (Brockway et al.,
2004). However, later in infection, nsp1 is distinct from
replication complexes and instead co-localizes with MHV
structural proteins at virion assembly sites (Brockway et al.,
2004). It has also been reported that exogenous MHV nsp1
expression induces cell-cycle arrest (Chen et al., 2004).
Together, these results led to the hypothesis that nsp1 may
participate in multiple stages of the MHV life cycle. Still,
the function of this protein remains a mystery as analysis of
nsp1 primary amino acid sequence does not reveal common
motifs or protein homologs, and the nsp1 crystal structure
has not been solved.
The goal of the current study was to determine the
role of nsp1 during MHV replication in cell culture and
to identify regions of the protein that are critical for its
function. Using the reverse genetic system for MHV
developed by Yount et al. (2002), genomic RNA
molecules that contained deletions or point mutations
within the nsp1-coding region were generated and tested
for their capacity to produce infectious virus following
transfection into permissive cells. The results demonstrate
that the carboxy-terminal half of nsp1 is dispensable for
replication in culture but is important for efficient
proteolytic cleavage of the protein and optimal viral
replication. In contrast, deletion of the entire nsp1 protein
or a middle region of the protein resulted in the lack of
virus recovered from electroporated cells. Analysis of
nsp1 point mutants identified residues important for viral
replication and RNA synthesis. The results of this study
provide valuable information regarding the possible
functions of the amino-terminal nsp1 protein in corona-
virus replication.Results
The carboxy-terminal half of nsp1 is dispensable for MHV
replication
To determine whether nsp1 is required for MHV
replication, viruses were engineered to lack nsp1 residues
A2 through L241 (nsp1DFL) or to express truncated formsof the protein lacking either Q87 through N164 (nsp1DMid) or
K124 through L241 (nsp1DC) (Fig. 1B). All deletion
constructs were designed to maintain the start codon, the
translational reading frame, and the minimal residues
thought to be required for cleavage of nsp1 from the
polyprotein by PLP1 (nsp1 residues K243 through G247)
(Hughes et al., 1995). Mutations were engineered into the
nsp1-coding region within the MHV infectious cDNA
(icMHV) fragment A plasmid. The mutagenized plasmids
were then used to assemble full-length MHV cDNA, which
was transcribed in vitro to yield MHV genomic RNA
(Yount et al., 2002). BHK-MHVR cells were electroporated
with either assembled wild-type (icwt) or nsp1 mutant
genomic RNA transcripts. Cells were incubated at 37 -C
and were monitored for syncytia formation, a cytopathic
effect (CPE) of MHV replication.
Virus-induced syncytia were detected at 24 h post-
electroporation (p.e.) in cells transfected with icwt
genomic RNA and at 72 h p.e. in cells transfected with
genomic RNA for the carboxy-terminal truncation mutant
(nsp1DC). Clarified cell culture media harvested from cells
electroporated with either icwt or nsp1DC RNA were
capable of initiating a productive infection in freshly
inoculated DBT-9 cells, demonstrating the presence of
viable virus. In contrast, cells electroporated with nsp1DFL
or nsp1DMid RNA showed foci containing 5–10 cell
nuclei at 72–96 h p.e., but these multi-nucleated foci did
not progress or spread over time like wild-type MHV
syncytia. The clarified media from cells electroporated
with nsp1DFL or nsp1DMid genomes were not capable of
producing CPE in freshly inoculated DBT-9 cells. This
result indicated that nsp1DFL and nsp1DMid were not
capable of completing a productive life cycle, defined by
the lack of infectious virus particles in the cell media
supernatant following electroporation. Nsp1DFL and
nsp1DMid RNA molecules were tested for their capacity
to produce viruses in three independent experiments, all of
which yielded this same result. The nsp1DC virus was
purified by three rounds of plaque isolation, and RT-PCR
was used to sequence across the entire nsp1-coding region.
The mutant virus maintained the engineered deletion and
had no other mutations within nsp1. These results
demonstrate that the carboxy-terminal half of nsp1 is
dispensable for MHV replication and suggest that deletion
of residues in the amino-terminal half is not tolerated for a
productive infection.
Charge-to-alanine mutagenesis of the nsp1 amino-terminus
The fact that nsp1DFL and nsp1DMid did not generate
productive infections suggests that this region of the
protein has a critical function in MHV replication.
However, it is also possible that the deletions removed
required RNA elements within the 5V end of the nsp1-
coding sequence. To investigate the function of the nsp1
amino-terminus with minimal disruption of the correspond-
Fig. 2. Single-cycle replication of nsp1 mutant viruses. (A) Replication
kinetics. Wild-type (icwt) or nsp1 mutant viruses were used to infect DBT-9
cells at an MOI of 5. Cells were rinsed three times with PBS, incubated
under medium at 37 -C, and samples of medium were obtained at the
indicated times post-infection. Viral titers in each sample were determined
using plaque assays on DBT-9 cells at 37 -C. The graph shows the results of
a representative experiment. Values are the averages obtained from
duplicate media samples. (B) Nsp1 mutant viral yield. To determine viral
yield, viral titer at 1 h p.i. was subtracted from peak titer for each virus. Bars
represent average viral yield calculated from the experiments (n = 3). Lines
represent standard error from the experiments. Statistical analysis software
was used to determine P values using a two-sample t test. Asterisks (*)
indicate P values  0.05. (C) Relative plaque size of icwt, VUSB1, and
VUSB4 (15 h p.i.). Images were obtained at the same resolution (10) on a
Nikon Eclipse TE2000-E microscope. White circles were drawn to facilitate
visualization of the plaque boundary.
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point mutations within this region. Mutations were intro-
duced into the icMHV fragment A plasmid using site-
directed mutagenesis. Single or paired charged residues (D,
E, R, K, and H) within the amino-terminal half of MHV nsp1
that are conserved across all group 2 coronaviruses were
substituted with alanine (Fig. 1B). Mutated fragment A
cDNAs were used as before to generate full-length genomic
viral RNA.
Virus-induced syncytia were detected within 24 h in
BHK-MHVR cells electroporated with either icwt RNA or
with RNA for nsp1 mutants VUSB1, VUSB2, VUSB3, or
VUSB7. The timing and extent of CPE following trans-
fection with these mutants were indistinguishable from icwt.
Cells transfected with RNA for VUSB4 exhibited CPE at
72 h p.e., similar to the kinetics observed with nsp1DC. The
clarified media supernatants from cells transfected with
VUSB1, VUSB2, VUSB3, VUSB4, or VUSB7 RNA were
capable of infecting DBT-9 cells, indicating that they
contained nsp1 mutant viruses. As with nsp1DC, the nsp1
point mutants were purified by three rounds of plaque
isolation, and RT-PCR was used to sequence across the
entire nsp1-coding region. The mutant viruses maintained
the engineered changes and lacked other mutations within
nsp1.
Similar to the results with nsp1DFL and nsp1DMid, cells
transfected with VUSB5 or VUSB6 RNA produced foci
containing 5–10 cell nuclei at 72–96 h p.e, but the extent of
these multi-nucleated foci did not increase over time.
Moreover, clarified media supernatant harvested from cells
transfected with VUSB5 or VUSB6 RNA did not generate a
productive infection following incubation with DBT-9 cells,
indicating that VUSB5 and VUSB6 were blocked at some
stage in the viral life cycle. VUSB5 and VUSB6 RNA
molecule were assayed for their capacity to produce viruses
in two independent experiments, both of which showed the
same result. It has been reported that charge-to-alanine
mutagenesis of viral proteins may generate temperature-
sensitive mutants (Hanley et al., 2002; Hassett and Condit,
1994; Tang et al., 2002). In the current study, nsp1 mutants
VUSB5, VUSB6, and nsp1DMid did not exhibit temper-
ature-sensitive phenotypes as no infectious virus was
recovered at either 37 -C or 32 -C. The nsp1DFL virus
was not tested at 32 -C.
Experiments were next performed to determine if viral
gene expression occurred in cells electroporated with RNA
for mutants that did not produce infectious virus (VUSB5,
VUSB6, nsp1DFL, and nsp1DMid). Using antisera against
MHV virions (a-MHV) or against nsp2 (a-nsp2), no viral
proteins could be detected by immunofluorescence or
immunoprecipitation (data not shown). Furthermore, no
specific products were amplified from electroporated cells
using RT-PCR and a primer that detects subgenomic RNAs
(data not shown). These results suggest that, if viral protein
or RNA expression occurred, it was below the level of
detection using these assays.Nsp1 mutant viruses exhibit viral replication defects
To determine whether mutagenesis of nsp1 results in viral
replication defects, single-cycle replication assays were
performed with the nsp1 mutants (Fig. 2). DBT-9 cells were
infected with icwt or nsp1 mutants (VUSB1, VUSB2,
VUSB3, VUSB4, VUSB7, or nsp1DC). Samples of infected
cell media supernatant were taken at various times from
1–24 h post-infection (p.i.), and viral titers in each sample
were determined by plaque assays.
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similar to icwt with peak virus release occurring between
12–16 h p.i. (Fig. 2A). However, several of the nsp1
mutants (VUSB1, VUSB 4, and nsp1DC) showed a
reduction in viral yield compared with icwt (Fig. 2B).
Whereas icwt gave an average yield of approximately 4.9 
106 PFU/ml, VUSB1, VUSB4, nsp1DC viruses exhibited
viral yields of 2.4  105, 1.4  106, 1.0  106 PFU/ml,
respectively. All of the nsp1 mutants exhibited decreased
yields; however, only the VUSB1, VUSB4, and nsp1DC
yields were statistically significant (P  0.05 using a two-
sample t test). VUSB1 and VUSB4 also demonstrated small
plaque phenotypes (Fig. 2C). These results indicate that
nsp1 mutants have replication defects in cultured DBT-9
cells.
Analysis of protein expression and processing from nsp1
mutant viruses
Nsp1 mutant viruses were evaluated to determine
whether they are defective in the expression or processing
of viral proteins (Fig. 3). Immunoprecipitation experiments
were performed to analyze processing of nsp1 and nsp2 or
3CLpro-mediated processing of nsp8. To confirm expres-
sion of the structural proteins, antisera raised against MHV
virions (a-MHV) were used. DBT-9 cells were either mock-
infected or infected with icwt or nsp1 mutants, radiolabeled
from 5–8 h p.i. with [35S]Met/Cys, and used to prepare
cytoplasmic lysates for immunoprecipitations.
Antisera against nsp1 (a-nsp1) immunoprecipitated a 28-
kDa protein (nsp1) from cells infected with icwt or the nsp1
point mutants (VUSB1, VUSB2, VUSB3, VUSB4, orFig. 3. Nsp1 mutant viral protein expression and processing. Cytoplasmic lysates w
(m) or infected with icwt or nsp1 mutant viruses. Labeled proteins were immunop
Proteins were resolved by SDS-PAGE in 5–18% polyacrylamide gradient gels an
film exposure. Bands corresponding to unique or predicted proteins are indica
kilodaltons) are shown on the left. The MHV structural proteins are designated as
for immunoprecipitation are indicated: (A) a-nsp1; (B) a-nsp2; (C) a-nsp8; andVUSB7) (Fig. 3A). Migration of VUSB7-nsp1 differed
from icwt and all other point mutants, suggesting differ-
ences in protein folding or charge. No 28-kDa proteins were
immunoprecipitated from mock-infected cell lysates or from
lysates generated from cells infected with the nsp1DC virus
(Fig. 3A). Rather, from nsp1DC-infected cell lysate, a-nsp1
immunoprecipitated a unique 14-kDa protein, the predicted
size of nsp1DC, as well as a previously undescribed 80-kDa
protein (Fig. 3A). In both VUSB4- and nsp1DC-infected
cells, several additional proteins (30 to 60 kDa) of unknown
identity were also precipitated using a-nsp1 (Fig. 3A).
Antisera against nsp2 (a-nsp2) immunoprecipitated a
65-kDa protein (nsp2) from all infected cell lysates, but
not from mock-infected lysates (Fig. 3B). Similar to the
result using a-nsp1, an 80-kDa protein was also detected by
a-nsp2 in nsp1DC-infected cells (Fig. 3B). Antisera against
nsp8 (a-nsp8) immunoprecipitated a 22-kDa protein (nsp8)
from all infected cell lysates, but not from mock-infected
cell lysates (Fig. 3C). The viral structural protein S, N, and
M were detected in all infected cell lysates using antisera
against virions (a-MHV) (Fig. 3D). The nsp1 mutants
showed band intensities slightly increased compared with
icwt. The reason for this difference in band intensity is
unknown but might be a reflection of more protein synthesis
or processing with the mutants at the time of label. Still,
although the amount of protein detected differed slightly, the
results show that amino-terminal nsp1 point mutants do not
have defects in their capacities to express or process viral
proteins. Nonetheless, the detection of an 80-kDa protein
from nsp1DC-infected cells using either a-nsp1 or a-nsp2
suggests that cleavage of nsp1DC from nsp2 may be
inefficient.ere generated from radiolabeled DBT-9 cells that were either mock-infected
recipitated from cytoplasmic lysates with the indicated polyclonal antisera.
d visualized following fluorography. Images were obtained following 4-day
ted on the right of the fluorograms, and molecular weight standards (in
follows: spike (S), nucleocapsid (N), and membrane (M). The antisera used
(D) a-MHV.
Fig. 4. Pulse-chase translation in nsp1DC virus-infected cells. Proteins in
infected DBT-9 cells were radiolabeled for 30 min with [35S]Met/Cys at 6 h
p.i. and then incubated in medium containing cyclohexamide for 15 to 360
min as described in Materials and methods. Cells were lysed at the
indicated times (min) post-chase (p.c.), and cytoplasmic lysates were
generated for immunoprecipitation studies using a-nsp1 and a-nsp2.
Proteins were analyzed as in Fig. 3. The identities of proteins are indicated
to the right of the fluorograms. The number of days the gels were exposed
to film (d exp) to generate the image is listed next to the antisera used for
immunoprecipitation. Pulse-chase translation in cells infected with (A) icwt
or (B) nsp1DC virus.
Fig. 5. Intracellular localization of mutant nsp1 proteins. DBT-9 cells grown
on glass coverslips were infected with icwt or nsp1 mutant viruses for 7 h,
fixed and permeablized with 100% methanol, and incubated with antibodies
against nsp1 (red), nsp2 (green), and N (purple). Cells were imaged using a
Zeiss LSM 510 confocal microscope at 546 nm (red), 488 nm (green), and
633 nm (purple). Images are single confocal slices obtained using a 40
objective. Co-localization of green and purple for VUSB1 is shown in the
merged image as light green pixels. Co-localization of all three colors is
shown in the merged images as white pixels. Multi-nucleated cells are a
cytopathic effect of MHV replication.
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Previous studies have shown that nsp1 is processed from
the gene 1 polyprotein very rapidly, and nsp1-containing
precursors have not been detected (Denison et al., 1992). In
contrast, nsp2 is processed with slower kinetics likely from
a 275-kDa nsp2–nsp3 precursor protein (Denison et al.,
1992, 1995; Harcourt et al., 2004; Schiller et al., 1998). To
determine the expression kinetics of the 80-kDa protein in
nsp1DC virus-infected cells and to determine whether this
protein is capable of being processed into 14-kDa (nsp1DC)
and 65-kDa (nsp2) proteins, pulse-chase translation experi-
ments were performed (Fig. 4). DBT-9 cells were infected
with either icwt or the nsp1DC virus, and proteins were
radiolabeled from 6–6.5 h p.i. with [35S]Met/Cys. Infected
cells were then chased in medium without radiolabel butcontaining cyclohexamide to inhibit new protein synthesis.
Cells were harvested at various times post-chase (p.c.), and
cytoplasmic lysates were generated for immunoprecipita-
tions using a-nsp1 and a-nsp2.
In the current study, the kinetics of nsp1 and nsp2
expression and processing in icwt-infected cells were
similar to published reports (Fig. 4A). Nsp1 was detected
as a mature 28-kDa protein at 0 min p.c., suggesting that this
protein was processed during the 30 min radiolabeling
period. Although nsp2 was detected as a mature 65-kDa
protein at 15 min p.c., nsp2 detection was increased at 60–
360 min p.c. The result that nsp1 and nsp2 remained
detectable even at 360 min p.c. suggested that these proteins
were stable. In these experiments, the 275-kDa nsp2–nsp3
precursor was not detected by a-nsp2.
Like nsp1 from icwt, nsp1DC (14 kDa) was detectable at
0 min p.c., indicating that processing at CS1 occurred within
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nsp1, nsp1DC was not detectable after 120 min p.c.,
suggesting that once processed the protein may be subject
to degradation. The kinetics of nsp2 expression in nsp1DC
virus-infected cells were similar to those of nsp2 from icwt
(Fig. 4B); nsp2 (65 kDa) was first detected at 0–15 min p.c.,
but detection was increased at 60–360 min p.c. Using either
a-nsp1 or a-nsp2, the 80-kDa protein was detectable by 0
min p.c. and remained stable or increasing until 240 min p.c.
At 360 min p.c., the 80-kDa band was slightly less intense;
however, at this time point, there was no concurrent increase
in nsp1DC or nsp2 detection. This result suggests that the
80-kDa protein may be degraded at late times of chase
rather than processed. As with icwt, the high molecular
weight nsp1DC viral precursor proteins were not detected
by the antisera.
Intracellular localization of nsp1 mutant viral proteins
During early times of infection (4–7 h p.i.), nsp1 co-
localizes with nsp2 and the viral nucleocapsid protein (N) at
viral replication complexes in the cytoplasm (Brockway et
al., 2004). At these times, nsp1 is mostly distinct from the
virion membrane protein (M), which localizes to sites of
particle assembly (Brockway et al., 2004). To determine the
intracellular localization of viral proteins from the nsp1
mutants, immunofluorescence confocal microscopy was
performed. DBT-9 cells on glass coverslips were infected
for 7 h, fixed and permeabilized with methanol, andFig. 6. Nsp1 mutant viral RNA levels. (A) Nsp1 mutant viral RNA levels represent
nsp1 mutant viruses. Actinomycin D was added to a final concentration of 20 Ag/
from 5–9 h p.i. and then precipitated from equal volumes of cytoplasmic lysates in
counts per minute (CPM), liquid scintillation was used. For each experiment (n =
mutant viral RNAwas calculated as a percentage of the icwt value. The bars repre
standard error. Statistical analysis software was used to determine P values using a
viral RNA. DBT-9 cells were mock-infected or infected with icwt or the indicated
using Trizol. RNA was isolated from cell lysates and normalized so as to elec
(approximately 400,000 CPM from a maximum of 106 cells). For the mock-infecte
0.8% formaldehyde/agarose gel, and individual RNA species were visualized follo
Individual viral RNA species are numbered to the right of the fluorogram (RNA 1
unique RNA band detected in nsp1DC virus-infected cells.incubated with antisera against nsp1, nsp2, and either N
or M (Fig. 5).
The a-nsp1 staining pattern in cells infected with VUSB2,
VUSB3, VUSB4, VUSB7, or nsp1DC was similar to icwt.
Nsp1 from these mutant viruses co-localized with nsp2 and
N in punctate cytoplasmic replication complexes (Fig. 5).
At this time point, the nsp1 proteins from VUSB2, VUSB3,
VUSB4, VUSB7, nsp1DC, or icwt viruses were also
distinct from sites of virion assembly as determined by
lack of predominant nsp1 co-localization with M (data not
shown). Using the a-nsp1 antisera, no specific staining
above background levels was detected in VUSB1-infected
cells, whereas nsp2, N, and M staining was indistinguish-
able from icwt (Fig. 5 and data not shown). The nsp1
antiserum is capable of detecting VUSB1-nsp1 by immu-
noprecipitation (Fig. 3A), demonstrating that the engineered
substitutions did not abolish the epitope(s). Therefore, the
lack of staining during immunofluorescence assays might
reflect alternative folding of VUSB1-nsp1. Nonetheless,
these results suggest that nsp1 mutant viruses do not have
defects in intracellular protein localization or replication
complex formation.
Levels of viral RNA in nsp1 mutant virus-infected DBT-9
cells
To investigate whether the nsp1 mutant viruses exhibit
changes in the timing or levels of viral RNA synthesis,
metabolic labeling assays were performed (Fig. 6). DBT-9ed as percent of icwt. DBT-9 cells were infected at an MOI of 5 with icwt or
ml 30 min prior to the addition of [3H]uridine. Viral RNAwas radiolabeled
replicate using trichloracetic acid. To quantitate [3H]uridine incorporation as
5), labeled viral RNA levels (CPM) for icwt were set to 100%, and nsp1
sent the average percent viral RNA from all experiments, and lines indicate
one-sample t test. Asterisks (*) indicate P values  0.05. (B) Gel analysis of
nsp1 mutants. RNAwas labeled as in panel (A) above, and cells were lysed
trophorese the same amount of radiolabeled viral RNA for each mutant
d control (m), RNA from 106 cells was used. The RNAwas separated in an
wing fluorography. The image is from a 2-day exposure of the gel to film.
= genome and RNA 2–7 = subgenomic RNAs). The asterisk (*) indicates a
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VUSB2, VUSB3, VUSB4, VUSB7, or nsp1DC). Viral RNAs
were radiolabeled from 1–13 h p.i. at intervals using 100
ACi/ml of [3H]uridine in the presence of Actinomycin D, a
drug that inhibits DNA-dependent RNA synthesis. RNA
was precipitated from cytoplasmic lysates using trichloro-
acetic acid, and 3H levels were quantitated using liquid
scintillation. The timing of RNA synthesis for the nsp1
mutants was indistinguishable from icwt, with all viruses
exhibiting maximal [3H]uridine incorporation when cells
were labeled between 5–9 h p.i. (data not shown). However,
the total levels of radiolabeled viral RNA differed among
the nsp1 mutants when compared with icwt. VUSB1 and
VUSB4 RNA levels were only 73% and 79% of icwt,
respectively, whereas VUSB3 RNA levels were 129% if
icwt (Fig. 6A). These data suggest that nsp1 may function at
the replication complex in the synthesis of viral RNA.
To determine whether nsp1 mutants have specific defects
in genome replication or subgenomic RNA synthesis,
radiolabeled viral RNA was analyzed by gel electrophoresis
(Fig. 6B). DBT-9 cells were either mock-infected or infected
with icwt or nsp1 mutant viruses, and RNA was labeled in
the presence of Actinomycin D from 5–9 h p.i. using
[3H]uridine. Total viral and cellular RNA was extracted
from cell lysates, and radioactivity in each sample was
quantitated using liquid scintillation. Equal amounts of
radiolabeled viral RNA (equal CPM) were separated by
electrophoresis in formaldehyde/agarose gels and then
visualized following fluorography. All seven species of
MHV viral RNAwere detected with the nsp1 mutant viruses
and icwt. Interestingly, with the nsp1DC virus, an additional
band that migrated above RNA4 was consistently detected.
The identity of this band is not known, but it might represent
a more stable replicative intermediate or a new subgenomic
RNA species. Still, the approximate ratio of RNA1
(genome) to RNA7 for each nsp1 mutant was similar to
that of icwt, suggesting that nsp1 mutants do not have
specific defects in either genome replication or subgenomic
RNA synthesis as detected by this assay.Discussion
Coronavirus gene 1 nsps are predicted to function in the
synthesis of viral RNA at cytoplasmic replication com-
plexes; however, many of these proteins have no known
roles during the viral life cycle. In the current study, a
reverse genetic approach was used to investigate the role of
nsp1 during MHV replication in cell culture and to identify
residues critical for its function. It was shown that viruses
containing deletions within nsp1 amino-terminal to K124 are
not capable of establishing productive infections, suggesting
that residues essential for MHV viability reside within the
amino-terminal half of the protein. Several such residues
were identified using point mutagenesis, and the importance
of the nsp1 for viral replication and RNA synthesis wascharacterized. Moreover, the results show that the carboxy-
terminal half of nsp1 is not required for MHV to complete
its life cycle but is necessary for efficient cleavage of nsp1
from the gene 1 polyprotein and for optimal viral rep-
lication. Together, these data are consistent with the
hypothesis that MHV nsp1 contains at least two domains
important for virus replication: (1) an essential amino-
terminal domain involved in viral RNA synthesis and (2) a
non-essential carboxy-terminal domain that influences CS1
cleavage efficiency.
Importance of the nsp1 amino-terminal domain
The analyses of MHV nsp1 deletion and point mutants
emphasize the significance of the amino-terminus for virus
viability, replication, and RNA synthesis. Deletion of
different portions of the nsp1 amino-terminal half, as was
done with nsp1DFL and nsp1DMid, was not tolerated for
virus viability. This result is consistent with the idea that
critical replication determinants reside within the region
spanning residues M1 through P123. Charge-to-alanine
mutagenesis identified four candidate residues (R64 and
E69 with VUSB5; R78 and D79 with VUSB6), all or any of
which may be vital for some stage of the MHV life cycle. In
cells transfected with RNA genomes for these non-
productive mutants (nsp1DFL, nsp1DMid, VUSB5, or
VUSB6), foci containing 5–10 cell nuclei were seen.
How these foci form in electroporated cell monolayers is
unknown, but the presence of this CPE suggests that
transient viral gene expression may have occurred. How-
ever, no viral protein was detected in transfected cell
monolayers by immunoprecipitation or immunofluores-
cence assays, and RT-PCR did not amplify subgenomic
RNA, indicating that, if gene expression occurred, it was
below the limits of detection using these assays. Conse-
quently, the exact stage of the MHV life cycle at which
these mutant viruses are blocked could not be determined.
Still, the result that nsp1DFL, nsp1DMid, VUSB5, or
VUSB6 did not establish productive infections underscores
the importance of the nsp1 amino-terminus and suggests
that this protein has a critical function during viral
replication.
In support of nsp1 having a central role in the MHV
life cycle, it was demonstrated that all of the viable nsp1
point mutants exhibited reduced viral yields during single-
cycle replication assays. VUSB1 and VUSB4 were the
most defective and resulted in viral titers approximately
0.2- to 1.3-log reduced compared with icwt. These two
viruses also exhibited small plaque phenotypes, suggesting
defects in cell-to-cell spread. The reduced replication and
small plaques seen with VUSB1 and VUSB4 are most
likely a reflection of reduced viral gene expression as both
of these nsp1 point mutants showed significantly lower
levels of viral RNA. Interestingly, compared with icwt,
VUSB3 had increased levels of viral RNA associated with
a slight reduction in viral replication, suggesting that any
Fig. 7. Model of icwt and nsp1DC virus protein processing. Shown are
schematics of wild-type and nsp1DC virus amino-terminal gene 1 nsps
(boxes). PLP1 and PLP2 are shown as gray boxes within nsp3. The
individual cleavage sites are labeled, and the order of processing is
indicated above the closed arrowheads. Lines below the protein schematics
illustrate the size of mature proteins following cleavage at individual sites.
(A) Processing of wild-type nsp1, nsp2, and nsp3. During infection, nsp1
(28 kDa) is cleaved rapidly at cleavage site 1 (CS1) as the polyprotein is
translated (indicated by forward slashes). Next, cleavage site 3 (CS3) is
processed to yield a 275-kDa nsp2–nsp3 precursor. Finally, cleavage site 2
(CS2) is cleaved to liberate nsp2 (65 kDa) and nsp3 (210 kDa). (B) Wild-
type pattern of processing for nsp1DC mutant. The order of cleavage for
nsp1DC mutant polyprotein is identical to that of icwt. Nsp1DC protein
(DC; 14 kDa) is liberated by CS1 cleavage. Next, CS3 is processed to yield
a 275-kDa nsp2–nsp3 precursor. Finally, CS2 is cleaved to liberate nsp2
(65 kDa) and nsp3 (210 kDa). (C) Alternative pattern of processing for
nsp1DC mutant. If CS1 is not initially cleaved, a 290-kDa nsp1DC–nsp2–
nsp3 precursor is made following CS3 processing. This precursor is then
cleaved at CS2 to yield an 80-kDa protein (nsp1DC–nsp2) and nsp3.
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impact viral replication. There were no detectable differ-
ences in the ratios of genome RNA versus subgenomic
RNAs for any of the viable nsp1 mutants. These results
suggest that nsp1 might play a role in the regulation of
total viral RNA amounts rather than in species-specific
viral RNA synthesis. It has been previously shown that
MHV mutants unable to liberate nsp1 from the gene 1
polyprotein (DCS1 mutants) exhibit phenotypes very
similar to the nsp1 mutant viruses described in this study
(Denison et al., 2004). Because the DCS1 mutations
resulted in a noncleaved nsp1-nsp2 fusion protein, it could
not be concluded that the viral phenotypes were solely
related to defects in nsp1 function. This study corroborates
and extends these previous findings and directly correlates
mutations in the MHV nsp1-coding region with changes in
viral replication and RNA synthesis.
The results of this study raise important questions
regarding the mechanistic basis for the described replication
and RNA synthesis defects with nsp1 mutants. Why is the
nsp1 amino-terminus required for MHV replication? What
function does this domain have during MHV RNA syn-
thesis? Do the deletion and point mutations change the
nature of nsp1–protein interactions? Yeast two-hybrid and
co-immunoprecipitation assays previously demonstrated
that wild-type nsp1 directly binds to nsp7 and nsp10, two
other gene 1 proteins (Brockway et al., 2004). The
interactions between nsp1, nsp7, and nsp10 do not require
the nsp1 carboxy-terminus (F167 through G247) but do
require residues amino-terminal to F167 (i.e., residues E84
through R166). Because the nsp1DMid virus was engineered
to lack this putative interaction domain, it is interesting to
speculate whether the lack of viability for this mutant
correlates with a loss of nsp1 binding to either nsp7 and/or
nsp10. Furthermore, it is thought that charge-to-alanine
mutagenesis alters a protein’s capacity to participate in inter-
and intra-molecular interactions (Cunningham and Wells,
1989). This mutagenesis approach is supposed to minimize
disruption of protein secondary structure; however, it is
possible that some of the charge-to-alanine mutations
caused nsp1 to misfold. In support of this possibility,
VUSB1-nsp1 was detected by a-nsp1 antisera during
immunoprecipitation assays but not during immunofluo-
rescence assays, suggesting that this mutant protein may
have a different structural conformation. Regardless, the
introduced mutations may have altered the capacity of nsp1
to bind to nsp7, nsp10, or other proteins resulting in viral
RNA synthesis and viral replication defects.
Importance of the nsp1 carboxy-terminal domain
During wild-type MHV infection, nsp1, nsp2, and nsp3
are processed in an ordered manner (Fig. 7A). Immediately
following translation of PLP1 within nsp3, CS1 is rapidly
cleaved, releasing nsp1 as polyprotein synthesis continues
(Denison et al., 1992, 1995; Harcourt et al., 2004; Schiller etal., 1998). Next, cleavage site 3 (CS3) is cleaved (likely by
PLP2) liberating an nsp2–nsp3 precursor, which is finally
processed at cleavage site 2 (CS2) to release mature nsp2
and nsp3 products (Denison et al., 1992, 1995; Harcourt et
al., 2004; Schiller et al., 1998). In nsp1DC virus-infected
cells, nsp1DC (14-kDa) and nsp2 are present, demonstrating
that the carboxy-terminal half of nsp1 is not absolutely
essential for cleavage at either CS1 or CS2. However, the
identification of an 80-kDa nsp1DC–nsp2 polypeptide in
nsp1DC virus-infected cells reveals that this region of the
protein (residues K124 through L241) is important for
efficient CS1 processing.
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model in which the nsp1DC gene 1 polyprotein exists in two
different conformations: a CS1 cleavable form and a CS1
non-cleavable from. If the mutant polyprotein is folded in
such a manner that CS1 is accessible by the proteinase, then
this site is cleaved normally and the mutant polyprotein
follows a wild-type pattern of processing (Fig. 7B).
Alternatively, if the mutant polyprotein is folded in a way
that masks CS1, this site is not processed and nsp1DC
remains fused to nsp2 (Fig. 7C). In this model, an nsp1DC–
nsp2–nsp3 precursor is the first processed protein following
CS3 cleavage. This polypeptide is then processed at CS2 to
yield the 80-kDa protein (nsp1DC–nsp2) and nsp3.
Although the high molecular weight precursors were not
detected in these studies, the kinetics of appearance for
nsp1DC, nsp2, and the 80-kDa protein are compatible with
the proposed model. During pulse-chase experiments,
nsp1DC and nsp2 are first detected in nsp1DC virus-infected
cells with the same timing as the corresponding nsp1 and
nsp2 proteins in icwt-infected cells. However, the expres-
sion kinetics for the 80-kDa protein are unlike either nsp1 or
nsp2, suggesting that the timing and order of polyprotein
processing are different under circumstances where CS1 is
not immediately cleaved. Whether the 80-kDa protein is
capable of being subsequently processed into nsp1DC and
nsp2 could not be determined from these studies. At
extended times p.c. (360 min), the 80-kDa protein is still
detectable, albeit at slightly reduced levels, and there is no
new accumulation of nsp1DC at this same time. These data
are most consistent with the idea that the 80-kDa protein is
not further processed once it is generated.
In addition to CS1 processing defects, the nsp1DC virus
also exhibits subtle replication defects, but normal viral
RNA synthesis levels, compared with icwt. A unique RNA
species migrating above RNA4 was detected in nsp1DC-
infected cells. The identity of this RNA band remains to be
determined, but it might represent a stable replicative
intermediate and implies that this mutant virus may have
minor defects in discontinuous transcription. Another
interesting possibility is that this band might represent a
new species of subgenomic RNA. Because some molecules
of nsp1DC are fused to nsp2, defects in nsp2 function may
contribute to the mutant viral phenotype. Alternatively, the
reduced replication of the nsp1DC virus might suggest that
nsp1 plays an important role downstream of viral RNA
synthesis, such as in virion assembly. At late times of
infection, wild-type nsp1 co-localizes with the MHV
structural protein M at virion assembly sites (Brockway et
al., 2004). Because the a-nsp1 antisera used in this study
also detects the 80-kDa nsp1DC–nsp2 protein, we were
unable to precisely determine whether the 14-kDa nsp1DC
protein is capable of localizing to virion assembly sites late
in infection. Nonetheless, it will be valuable to determine
whether nsp1DC, or any of the mutant nsp1 proteins, exhibit
differences in protein localization during late times of
infection.In summary, the phenotypes of these MHV mutant
viruses reveal new information about the possible roles of
nsp1 during viral replication. However, it is important to
note the limitations of the reverse genetic approach used in
this study and to explore alternative explanations of the
available data. For example, it has been reported that
exogenous MHV nsp1 expression induces cell-cycle arrest
(Chen et al., 2004). Therefore, it is also possible that the
nsp1 mutations have an indirect effect on MHV replication
as a result of cell biological changes during infection.
Moreover, while it is clear that some of the nsp1 mutants
have differences in nsp1 confirmation and interactions, it is
possible that uncharacterized RNA structural elements have
also been disrupted as a result of nsp1 mutagenesis resulting
in changes in viral RNA synthesis and replication. Fur-
thermore, in the absence of sequencing the entire 32-kb
genomes of the nsp1 mutant viruses, the possibility that
other mutations contribute to the described phenotypes
cannot be excluded. To rule out the contributions of other
mutations or RNA elements, wild-type nsp1 expressed in
cells must complement the defects of these viruses. While
ideal, trans-complementation using protein expression has
not been successful for coronaviruses. In fact, efficient
complementation for other positive-strand RNA viruses has
required the development of replicon systems to facilitate
viral replication complex formation (Appel et al., 2005;
Grassmann et al., 2001; Khromykh et al., 1998; Lindenbach
and Rice, 1997; Liu et al., 2002). Despite these limitations,
this is the first report of detailed mutagenesis of an MHV
gene 1 nsp-coding region within the context of a virus.
These results will enhance our knowledge of MHV
replication determinants, and future analysis of nsp1 mutant
viruses will provide greater insight into the function of RNA
and protein elements within the 5V end of gene 1. Even
more, studies with these engineered mutant viruses are
expected to contribute to understanding the replication
strategies of other coronaviruses, such as SARS-CoV.Materials and methods
Cells and antisera
Delayed brain tumor cells selected for high-level
expression of the MHV receptor carcino-embryonic antigen
cell adhesion molecule-1 (DBT-9) (Chen et al., 1997;
Hirano et al., 1976; Yount et al., 2002) and baby hamster
kidney-21 cells expressing the MHV receptor (BHK-
MHVR) (Chen et al., 1997; Yount et al., 2002) were grown
in Dulbecco’s modified Eagle medium (DMEM) (Gibco)
that was supplemented with 10% heat-inactivated fetal calf
serum (FCS) (Sigma) for all experiments. Medium for
BHK-MHVR cells was supplemented with G418 (800 Ag/
ml) to select for cells expressing the MHV receptor.
Polyclonal antisera used for biochemical and immuno-
fluorescence experiments have been previously described.
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et al., 2004); rabbit a-nsp2 antisera (VU153) (Sims et al.,
2000); rabbit a-nsp8 antisera (p1a-22) (Bost et al., 2000);
and rabbit a-MHV antisera generated against intact virions
(Denison et al., 1999). J. Fleming (University of Wisconsin,
Madison) kindly provided murine monoclonal antibodies
specific for the structural proteins nucleocapsid (a-N, J.3.3)
and membrane protein (a-M, J.1.3).
Nsp1 deletion mutagenesis of MHV-A59 infectious clone
fragment A plasmids
To delete portions of the nsp1-coding sequence, PCR
was performed using the icMHV-A59 fragment A plasmid
(pCR-XL-TopoA) as template (Yount et al., 2002). To
generate nsp1DFL, deleting nearly the entire nsp1-coding
sequence (nsp1 amino acids A2 through L241), a PCR
product was amplified using oligodeoxynucleotide primers
(sense) 5V-GTT TAA ACG AGA CAT AAT ACG-3V and
(antisense) 5V-CTT AAG CAT TAT GCA ACC TAT-3V. To
generate nsp1DMid, deleting the middle portion of nsp1
(Q87 through N164), two separate PCR products were
amplified. The first PCR reaction used primers (sense) 5V-
CCG CCG GCC TGG TCT TGT-3V and (antisense) 5V-GGA
TCC TCA TCT ACA AA-3V to amplify sequences corre-
sponding to the 5VUTR and the amino-terminal 86 residues
(M1 through P86) of nsp1. The second reaction used primers
(sense) 5V-GAT CCC GGC CGT TTT ATA GGC-3V and
(antisense) 5V-CTT AAG AAG AGC ATA-3V to amplify
sequences corresponding to the carboxy-terminal 78 resi-
dues (G165 through L241). To generate nsp1DC, deleting the
carboxy-terminus of nsp1 (K124 through L241), a PCR
product was amplified using primers (sense) 5V-CCG CCG
GCC TGG TCT TGT-3V and (antisense) 5V-CTT AAG GGG
AAG CAC ACC CAA-3V.
All PCR products were ligated into pGEM-T-Easy
(Promega) and sequenced to ensure the fidelity of PCR.
Nsp1 sequences were then subcloned into pCR-XL-TopoA
in place of wild-type nsp1 using primer-generated restriction
sites: nsp1DFL (5VPmeI to 3VAflII), nsp1DMid (first ligated
at the BamHI site then subcloned into pCR-XL-TopoA
using 5V SacII and 3VAflII), and nsp1DC (5V SacII to 3VAflII).
All fragment A plasmids were sequenced across the nsp1-
coding region to ensure proper ligation and maintenance of
the translational reading frame.
Nsp1 charge-to-alanine mutagenesis of MHV-A59 infectious
clone fragment A plasmids
The MHV-A59 nucleotides (nt) 103 to 954 (restriction
sites 5V SacII to 3VAflII) were PCR amplified using pCR-XL-
TopoA as template and cloned into pGEM-T-Easy to
generate pGEM-nsp1. Charge-to-alanine substitutions were
introduced into pGEM-nsp1 using complementary pairs of
mutagenic primers and the QuikChange Site-Directed
Mutagenesis Kit (Stratagene).Primers used to introduce alanine codons (underlined) are:
(VUSB1) 5V-C ATA GGT TGC ATA ATG GCA GCA
ATG GGC GCA TAC GGT CTC GGC TCC-3V;
(VUSB2) 5V-GG ATG CTT CCG AAC GCA TCG
GCA GCA TTG GGT AAC CCT GAG-3V; (VUSB3)
5V-CCC TCT GCT GAG CAA GCA CCG GCA GTT
AAA GGA AAA ACT TTG-3V; (VUSB4) 5V-GGA AAA
ACT TTG GTT AAT GCA GTG AAG GTG AAT TGT
AGC CGG-3V; (VUSB5) 5V-G AGG GTG AAT TGT
AGC GCA CTT CCA GCT TTG GCA TGC TGT GTT
CAG TC-3V; (VUSB6) 5V-GTT CAG TGT GCC ATA
ATC GCA GCA ATT TTT GTA GAT GAG GAT CCC
C-3V; (VUSB7) 5V-GAT GAG GAT CCC CAG GCA
GTG GCA GCC TCA ACT ATG ATG GC-3V
Mutagenized pGEM-nsp1 plasmids were sequenced to
verify the incorporation of the appropriate substitutions and
the fidelity of PCR. Restriction enzyme sites 5V SacII and
3VAflII were then used to subclone mutant nsp1 sequences
into pCR-XL-TopoA in place of the wild-type nsp1
sequence.
Generation of nsp1 mutant viruses
Viruses containing nsp1 mutations were produced using
the infectious clone strategy for MHV-A59 (icMHV)
described by Yount et al. (2002) and modified by Denison
et al. (2004). All assembled viruses, including the wild-
type control (icwt), were generated using the icMHV
fragment F plasmid corresponding to the virulent VUSS3
strain (Sperry et al., 2005). Plasmids containing the cDNA
cassettes of the MHV genome were digested using MluI
and BsmBI for fragment A, BglI and BsmBI for fragments
B and C, NciI and BsmBI for fragments D and E, BsmBI
for F, and SfiI and BsmBI for fragment G. Gel purified
restriction fragments were ligated together using T4 DNA
ligase (New England Biolabs) in a total reaction volume
of 150 Al at 16 -C overnight. Following chloroform
extraction and isopropanol precipitation of ligated cDNA,
full-length transcripts of icMHV RNA were generated in
vitro using the mMessage mMachine T7 Transcription Kit
(Ambion) according to the manufacturer’s protocol with
the following modifications. Fifty microliter reactions were
supplemented with 7.5 Al of 30 mM GTP, and transcription
was performed at 40.5 -C for 25 min, 37.5 -C for 50 min,
and 40.5 -C for 25 min. In parallel, RNA transcripts
encoding the MHV nucleocapsid protein (N) were gen-
erated from N cDNA. N transcripts and icMHV genomic
RNA were then mixed and electroporated into BHK-
MHVR cells. Briefly, BHK-MHVR cells were grown to
sub-confluence, trypsinized, then washed twice with
phosphate-buffered saline (PBS) and resuspended in PBS
at 107 cells/ml. Six hundred microliters cells were then
added to RNA transcripts in a 4-mm gap electroporation
cuvette, and three electrical pulses of 850 V at 25 AF were
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Transfected cells were then seeded on a monolayer of 106
uninfected DBT-9 cells in a 150 cm2 flask and incubated at
either 37 -C or 32 -C for 24 to 96 h. Virus viability was
determined by syncytia formation in the electroporated cell
culture and by the capacity of the clarified transfected cell
supernatant to induce syncytia in a monolayer of fresh
DBT-9 cells.
Plaque purification, RT-PCR, and sequencing
Mutant viruses were subjected to three rounds of plaque
purification, and reverse transcription (RT)-PCR was used
to amplify the 5V end of the viral genome for sequence
analysis. RNA was harvested from infected DBT-9 cells
using Trizol (Invitrogen) according to the manufacturer’s
protocol and used as template for RT-PCR. To generate viral
cDNA, reverse transcription was performed using Super-
script II RT (Invitrogen) and an antisense primer compli-
mentary to nt 5531–5500 of the MHV-A59 genome. The
nsp1-coding region was then amplified using PCR with
primers corresponding to nt 284–302 (sense) and nt 1150–
1165 (antisense). The resulting amplicons were sequenced
across the nsp1-coding region to confirm the retention of the
introduced nsp1 mutations and the absence of second-site
mutations.
Single-cycle replication assays
Viable nsp1 mutant viruses were analyzed for replication
using single-cycle replication assays as previously described
(Denison et al., 2004). Briefly, DBT-9 cells (approximately
106 cells) were infected at an MOI of 5 PFU/cell with icwt
or nsp1 mutant viruses. Virus inoculum was removed
following 30 min adsorption at 25 -C, and cells were
washed three times with PBS. Cells were then incubated at
37 -C in fresh pre-warmed DMEM with 10% FCS, and
samples of medium were collected at various times up to
24 h post-infection (p.i.). Viral titers in the medium were
determined by plaque assay (Hirano et al., 1976). To
determine viral yield, titer at 1 h p.i. was subtracted from
peak titer for each virus, and an average was calculated
using data from three separate experiments. Data analysis
was performed using Smith’s Statistical Package-Version
2.75. A two-sample t test was performed for each virus
(P value  0.05).
For imaging relative plaque size, confluent DBT-9 cells
in 60-mm culture dishes were infected with serial dilutions
of icwt, VUSB1, or VUSB4 virus and then were overlaid
with 1% agar–DMEM supplemented with 10% FCS. At
15 h p.i., the agar medium was removed, and the cells were
fixed for 30 min using 20 -C 100% methanol. Cells were
incubated in PBS for 30 min, and then images of plaques
were obtained on a Nikon Eclipse TE2000-E microscope
using a 10 objective. Images were prepared using Adobe
Photoshop 8.0 (Adobe).Radiolabeling and immunoprecipitation of viral proteins
DBT-9 cells (approximately 3  106 cells) were either
infected at an MOI of 5 or mock-infected using DMEM with
10% FCS. At 2.5 h p.i., the medium was replaced with fresh
DMEM lacking methionine and cysteine and supplemented
with 5% FCS and Actinomycin D (5 Ag/ml). Proteins were
radiolabeled from 5–8 h p.i. using 100 ACi/ml of [35S]Met/
Cys (Translabel; ICN). For pulse-chase analysis, proteins
were radiolabeled from 6–6.5 h p.i. and then chased for
various times with DMEM supplemented with 10% FCS
and cyclohexamide (250 Ag/ml). Cells were washed using
500 Al of PBS and then lysed in 300 Al of lysis buffer
containing 150 mM NaCl, 1% NP40, 0.5% DOC, 50 mM
Tris pH 8.0. Lysates were subjected to centrifugation at
3500  g to remove cell nuclei.
Immunoprecipitations were performed in a final
volume of 500 Al using protein A–Sepharose beads
(Sigma), 100 Al of radiolabeled cytoplasmic lysate
(derived from approximately 106 cells) which was boiled
for 5 min in 1% SDS, and 2–10 Al of polyclonal antisera
in immunoprecipitation buffer containing 300 mM NaCl,
0.1% SDS, 0.5% TX-100, 4 mM EDTA, 0.1% DTT, and
50 mM Tris pH 7.4. Immunoprecipitation reactions were
incubated at 4 -C for 4 h with rotation. Protein–bead
conjugates were washed three times in immunoprecipita-
tion buffer, and proteins were eluted from beads by
boiling for 5 min in 2 protein loading buffer (200 mM
DTT, 100 mM Tris pH 6.8, 0.04% bromophenol blue,
20% glycerol). Proteins were resolved by SDS-PAGE in
5–18% polyacrylamide gradient gels and analyzed by
fluorography. The [14C] high molecular weight standard
(Gibco) and full-range rainbow marker (Invitrogen) were
used as molecular weight standards. Images were pre-
pared using Adobe Photoshop 8.0 (Adobe).
Immunofluorescence assays
DBT-9 cells cultured on glass coverslips were either
mock-infected or infected at an MOI of 5 at 25 -C for 30
min. Following virus adsorption, infected medium was
replaced with pre-warmed DMEM with 10% FCS, and cells
were incubated at 37 -C. At 7 h p.i., cells were fixed and
permeablized with 20 -C 100% methanol for a minimum
of 30 min. Indirect immunofluorescence assays were
performed as previously described (Bost et al., 2000).
GP3 was used at 1:2000 dilution, and all rabbit polyclonal
antisera were used at 1:100 dilution. Murine monoclonal
antibodies were used at 1:1000 dilution. Secondary anti-
bodies conjugated to fluorophores (Molecular Probes) were
used at 1:1000 and included a-guinea pig-Alexa 546, a-
rabbit-Alexa 488, and a-murine-Alexa 633. Immunofluo-
rescence was detected using a Zeiss LSM 510 laser scanning
confocal microscope with a 40 oil immersion objective.
Image analysis and merging were performed using Adobe
Photoshop 8.0 (Adobe).
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DBT-9 cells (approximately 106 cells) were infected at an
MOI of 5 with icwt or nsp1 mutant viruses. Virus inoculum
was removed following 30 min adsorption at 25 -C, and
cells were washed three times with PBS. Cells were then
incubated for various times in fresh pre-warmed DMEM
with 10% FCS at 37 -C. At 30 min prior to addition of
radiolabel, cell medium was supplemented with Actino-
mycin D (5 Ag/ml). Viral RNAwas metabolically labeled in
the presence of Actinomycin D using 100 ACi/ml [3H]uri-
dine. To harvest viral RNA, cells were washed twice with
PBS and then lysed with 300 Al of cell lysis buffer (150 mM
NaCl, 1% NP40, 0.5% DOC and 50 mM Tris pH 8.0).
Lysates were centrifuged at 3500  g to remove nuclei, and
RNA in 100 Al of cytoplasmic extract was precipitated in
replicate using 10% trichloroacetic acid. Precipitated RNA
was dried onto glass microfiber filters (Whatman) using
vacuum filtration, and radioactivity was measured as counts
per minute (CPM) using a liquid scintillation counter
(Beckman). Statistical analysis software (Smith’s Statistical
Package-Version 2.75) was used for data analysis. For each
experiment (n = 5), icwt values (CPM) from the 5–9 h time
intervals were set to equal 100%. And, nsp1 mutant values
were calculated as percent of icwt. One-sample t tests were
performed using a P value  0.05.
Analysis of [3H] viral RNA by gel electrophoresis was
performed as described previously (Kim et al., 1995) with a
few modifications. Viral RNA was radiolabeled from 5–9 h
p.i. as before and was isolated using Trizol (Invitrogen)
according to the manufacturer’s protocol. The amount of
[3H] incorporation was quantitated using liquid scintillation.
Equal amounts of radiolabeled viral RNA (approximately
400,000 CPM from a maximum of 106 cells) were
denatured in formamide gel loading buffer at 65 -C for 10
min and then electrophoresed in a 0.8% formaldehyde/
agarose gel at 144 V for 4 h. For mock-infected samples,
RNA from 106 cells was used. Following electrophoresis,
the gel was incubated in 100% methanol for 2 h then in 1%
diphenyloxazole/methanol for 2 h prior to overnight
incubation in distilled water. The gel was dried at 50 -C
using vacuum filtration before exposing it to film. Images
were prepared using Adobe Photoshop 8.0 (Adobe).Acknowledgments
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